DYNAMIKA™

DYNAMIKA™: Your One Stop for Clinical Trial Imaging.

Designed to accelerate the next wave of drug development for biopharma, CROs, and researchers. An AI-enabled platform that delivers faster, more reliable imaging endpoints, driving regulatory success and accelerating drug development.

Get A Demo Today

0

Years of Imaging Expertise!

0

Clinical Trials Supported

Global

Site & Investigator Network

Compliance & Certificates

SOC 2 TYPE II

HHS-Seal

GDPR

FDA 21 CFR Part 11

ISO 13485

Better Imaging, Better Outcomes - Your Image Matters To Us

DYNAMIKA™: Redefining Imaging in Clinical Trials

Reduced Site Burden 1.

Streamlined workflows with automated anonymization and quality checks at upload.

Fast Start-Up 2.

Get your first patient scan faster with rapid configuration.

Central Image Review 3.

Access the richest library of AI-enabled and advanced image analysis methods. Interoperable with other industry-recognized reading applications.

AI - Powered Endpoints 4.

Proprietary imaging assessment and read methodologies to reveal early efficiency of novel drug candidates

DYNAMIKA™: Trusted By Sponsors Worldwide

Our Partnerships.

NOVADIP

PIERIS

ALTRUBIO

SCC-RI

ZITELAB

WPD PHARMACEUTICALS

CELLSIGHT TECHNOLOGIES

GENENTA

FERRING PHARMACEUTICALS

CRESCENDO

LILLY

IMV

MIMEDX

CNS

TERGETEX

VIVACITAS

MOBILITY BIO

AMGEN

UNIVERCITY OF LEEDS

TAKEDA

SORICIMED BIOPHARMA

PETER MAC

MEDICENNA

DYNAMIKA™

One solution for all your clinical trial imaging needs

Simplify complex data and image management through automated workflows.

Go faster Track site, reader, and CRO performance across all stakeholders in real time.

Gain transparency Track site, reader, and CRO performance across all stakeholders in real time.

Make confident decisions Leverage consistent, high‑quality imaging data for regulatory submissions.

Focus on what matters Improve trial outcomes by eliminating complexity in imaging management.

Your Image Matters To Us

Why Partner With Image Analysis Group

Industry-Leading Expertise in Imaging Clinical Trials

IAG brings two decades of global experience in designing and executing imaging endpoints for Phase I-III studies, supporting biotech and pharma companies in oncology, immunology, neurology, and more

Advanced, AI-Powered Imaging Platform DYNAMIKA™

Benefit from DYNAMIKA™, our award-winning cloud-based platform for imaging data management, central review, and regulatory-grade analytics. Unlock early efficacy, robust safety insights, and transparency across stakeholders—accelerating development and maximizing trial success.

Global Site Network & World-Class Radiology Experts

Tap into IAG’s vast network of imaging sites, expert radiologists, and project managers across North America, EU, UK, India, and China for comprehensive support in both global and regional trials.

Accelerate Trial Timelines & De-Risk Development

With predictive imaging biomarkers and AI-powered endpoints, IAG helps sponsors achieve faster patient recruitment, real-time oversight, and rapid database lock, lowering R&D risks while improving trial outcomes.

What We Do

Clinical Imaging Services for Every Phase of Your Programme.

Find the engagement model that matches where your trial is today — from retrospective data collection to AI-enabled real-world evidence.

Collect & Hold

Budget-friendly retrospective image collection and secure archival — capture your trial data now and analyse when your protocol is ready.

Learn more

Early Phase Trials

Efficacy, safety, and mechanism-of-action mapping with sensitive imaging biomarkers for confident go / no-go decisions.

Learn more

Late Phase Trials

Global pivotal studies with harmonized acquisition and independent central reads that deliver regulator-ready endpoints.

Learn more

RWE & AI Studies

Real-world evidence integration and AI-powered radiomics that extend the scientific value of your imaging dataset.

Learn more

DYNAMIKA™ FAQs

Frequently Asked Questions

What is DYNAMIKA?

DYNAMIKA is a cloud-based platform for managing medical images in clinical trials. Sites upload scans to it, quality checks run automatically, radiologists read the images against defined criteria inside it, and the results come out as data ready for regulatory submission. It's built and operated by Image Analysis Group.

Who is it for?

Biotech and pharma companies running trials where imaging is used to measure whether a treatment works and the CROs supporting them. If your protocol includes MRI, CT, PET, X-ray or ultrasound at defined timepoints, it applies to you.

Why do trials need an imaging platform at all, why not just collect the scans?

Because scans collected inconsistently can't support an endpoint. Sites use different scanners and protocols, images arrive in different states, and readers interpret them differently. A central platform standardizes how images are captured, checked and read, so the result holds up under regulatory review.

What is central image review?

Independent radiologists, blinded to treatment allocation, read every scan against pre-defined criteria, rather than each site reading its own. Where the protocol requires it, two readers assess independently and a third adjudicates any disagreement. It's what regulators generally expect when imaging supports an efficacy endpoint.

When in our study should we get in touch?

Earlier than most sponsors expect. Endpoint definition, imaging charter design and checking scanner capability at your candidate sites all happen before the protocol is final, and they're costly to revisit later. If imaging is in your protocol, it's not too early to talk.

Speak to our expert team today

Contact Us Today

Learn how Improve trial outcomes by eliminating complexity in imaging management with DYNAMIKA™

DYNAMIKA™: Your One Stop for Clinical Trial Imaging.

DYNAMIKA™: Redefining Imaging in Clinical Trials

Our Partnerships.

One solution for all your clinical trial imaging needs

Why Partner With Image Analysis Group

Clinical Imaging Services for Every Phase of Your Programme.

Frequently Asked Questions

Contact Us Today

Submit RFP